Managers / Q2 2023 · view latest →
Sofinnova Investments, Inc.
CIK 0001631134 · 3000 Sand Hill Road, BUILDING 3-SUITE 150, Menlo Park, CA, 94025 · 650.681.8428
Reported Value
$1.5B
Q2 2023
Positions
55
Filings on Record
33
2019–present window
Filed
Aug 14, 2023
original filing
Summary
Sofinnova Investments, Inc. reported $1.5B in U.S.-listed holdings across 55 positions for Q2 2023.
Its largest position, Karuna Therapeutics, represents 19.6% of the portfolio.
Compared with Q1 2023, the fund opened 13 new positions and exited 16.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q2 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $2.6B | 75 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $2.3B | 60 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.8B | 62 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.6B | 63 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.5B | 65 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.4B | 61 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.3B | 62 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.8B | 64 | Aug 15, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2024 | $1.8B | 74 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.8B | 64 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.6B | 69 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.5B | 55 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.6B | 53 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.69T | 53 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.7B | 61 | Nov 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.2B | 61 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.3B | 64 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.7B | 72 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.7B | 70 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.7B | 67 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $1.7B | 64 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $1.7B | 69 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.3B | 157 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.6B | 186 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.1B | 150 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.4B | 135 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.1B | 167 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.1B | 163 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.0B | 164 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $803M | 137 | Feb 22, 2019 | RESTATEMENT | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.